Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Diehl

Showing results (41-50 of 647) with videos related to

Pageof 65
Sort By:
Der Internist|October 27, 1998
[Economic evaluation within the scope of clinical studies]R Walshe, V Diehl
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1980
[Cooperation between oncologists and psychosomatic physicians in the treatment of solid tumors]V Diehl, H Freyberger
Onkologie|June 1, 1987
[Clinical relevance of immunotyping of oncologic and hematologic diseases]V Diehl, M Pfreundschuh
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Controversies in the management of non-Hodgkin lymphomaA Engert, V Diehl
The New England Journal of Medicine|February 16, 1995
Hodgkin's disease--environmental or genetic?V Diehl, H Tesch
Medizinische Klinik (Munich, Germany : 1983). Supplement|November 1, 1993
[Taxanes--a new generation of cytostatic drugs]V Diehl, T Steinmetz
Cancer Investigation|June 17, 2006
Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma?V Diehl, K Behringer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategiesV Diehl, M Fuchs
European Journal of Haematology. Supplementum|August 7, 2001
The role of ifosfamide in cytoreduction, stem cell mobilization and high-dose therapy in relapsed/refractory malignant lymphomasF B Hagemeister, V Diehl
Der Internist|May 22, 2004
[Malignant lymphoma competence network]A Herrmann-Frank, V Diehl
Pageof 65

Showing results (41-50 of 647) with videos related to

Sort By:
Pageof 65
Der Internist|October 27, 1998
[Economic evaluation within the scope of clinical studies]R Walshe, V Diehl
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1980
[Cooperation between oncologists and psychosomatic physicians in the treatment of solid tumors]V Diehl, H Freyberger
Onkologie|June 1, 1987
[Clinical relevance of immunotyping of oncologic and hematologic diseases]V Diehl, M Pfreundschuh
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Controversies in the management of non-Hodgkin lymphomaA Engert, V Diehl
The New England Journal of Medicine|February 16, 1995
Hodgkin's disease--environmental or genetic?V Diehl, H Tesch
Medizinische Klinik (Munich, Germany : 1983). Supplement|November 1, 1993
[Taxanes--a new generation of cytostatic drugs]V Diehl, T Steinmetz
Cancer Investigation|June 17, 2006
Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma?V Diehl, K Behringer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategiesV Diehl, M Fuchs
European Journal of Haematology. Supplementum|August 7, 2001
The role of ifosfamide in cytoreduction, stem cell mobilization and high-dose therapy in relapsed/refractory malignant lymphomasF B Hagemeister, V Diehl
Der Internist|May 22, 2004
[Malignant lymphoma competence network]A Herrmann-Frank, V Diehl
Pageof 65